Portfolio company
Astarte Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical intelligence company develops software and predictive analytics to standardise feeding and optimise nutrition for preterm infants in neonatal intensive care units.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Astarte
This company provides clinical decision support software to hospital neonatal intensive care units for monitoring and standardising nutrition and feeding protocols for preterm infants.
Neobiomics
This company develops and provides clinical nutritional products, including probiotic blends and fatty acid oils, for preterm infants in neonatal intensive care units.
SIME Clinical AI
This company develops an AI platform and point-of-care devices for rapid respiratory disease prediction and diagnostics in neonatal and adult intensive care units.
AngelEye Health
This company develops a patient engagement platform for neonatal and paediatric intensive care units to provide video monitoring, feeding management and communication tools.
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
Innocens
Innocens develops an artificial intelligence platform for neonatal intensive care units to detect sepsis and monitor patient deterioration for clinicians and hospitals.
Lucina Health
This company develops a data analytics platform and care management tools for health plans to identify pregnancy risks and prevent preterm births.
NOMA AI
This company develops a machine learning platform that monitors real-time clinical data to help hospital teams identify risks of medical complications and maternal haemorrhage.
